Module 17 2024

03/12/2024

NICE MedTech recommendations

Product has potential to provide substantial benefits, but uncertainty about whether these are realisable in normal clinical settings Adoption optimised OR Research recommended

Evidence shows sufficient certainty of benefit

Significant uncertainty, or certainty of no benefit

Case supported

Case not supported

Use (with standard NICE implementation or “deeper” adoption support - NTAC)

Use in subgroup OR NICE/EAC supports development of evidence

Not for current use

15

Expert Input

They are healthcare professionals with expertise in the clinical area for which the medical technology is used and often are familiar with the technology

Specialist commentators are identified by NICE

2 main pools of experts: clinicians and nurses

16

8